FindTrial
Sign In

Application of ultrasound guided nerve block in patients with pacemaker or implantable cardioverter–defibrillator placement

Application of ultrasound guided nerve block in patients with pacemaker or implantable cardioverter–defibrillator placement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032318
Enrollment
Unknown
Registered
2020-04-25
Start date
2020-05-06
Completion date
Unknown
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia

Interventions

Group C:Sham nervel block
Group N:Nervl block

Sponsors

First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 90 Years

Inclusion criteria

Inclusion criteria: Patients with pacemaker and implantable cardioverter defibrillator under cardiopulmonary bypass are not limited to men and women. They are 0-90 years old. Their body mass index (BMI) is 17.9-24.9, ASA II - III, and their cardiac function is classified as NYHA I - III.

Exclusion criteria

Exclusion criteria: Patients with thoracic malformation who can not be blocked, whose left ventricular ejection fraction is less than 40%, who have diabetes history and infection.

Design outcomes

Primary

MeasureTime frame
VAS score within 48 hours;Total dosage of sufentanil during perioperative period;MOPS score within 48 hours after operation;—

Secondary

MeasureTime frame
Recovery time of anesthesia;Postoperative nausea and vomiting;Postoperative exhaust time;Postoperative defecation time;Hospitalization days;Pacemaker function;implantable cardioverter–defibrillator placement function;—

Countries

China

Contacts

Public ContactYang Zhang

The First Affiliated Hospital of Nanchang University

mzzhangyang@126.com13576080494

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026